M&A Deal Summary

Zymergen Acquires Radiant Genomics

On January 8, 2018, Zymergen acquired life science company Radiant Genomics from Metagenics

Acquisition Highlights
  • This is Zymergen’s 1st transaction in the Life Science sector.
  • This is Zymergen’s 1st transaction in the United States.
  • This is Zymergen’s 1st transaction in California.

M&A Deal Summary

Date 2018-01-08
Target Radiant Genomics
Sector Life Science
Buyer(s) Zymergen
Sellers(s) Metagenics
Deal Type Divestiture

Target

Radiant Genomics

Emeryville, California, United States
Radiant Genomics, Inc. is a provider of an integrating a range of novel technologies including large-scale sequencing, synthetic biology, bioinformatics, cloud computing, metabolic engineering, and high-throughput analytical chemistry to develop a robust industrial platform for natural product discovery, diversification, and production. Radiant Genomics utilizes this platform to develop products in numerous market categories including pharmaceuticals, agriculture, specialty chemicals, and nutraceuticals.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Zymergen

Emeryville, California, United States

Category Company
Founded 2013
Sector Information Technology
Revenue 17M USD (2021)
DESCRIPTION

Zymergen is a science and material innovation company rethinking biology and reimagining the world. The company partners with nature to create never-before-imagined materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more. It creates sustainable materials that are in use today, delivering value for Fortune 1000 companies with over $1 billion worth of products using Zymergen microbial innovations sold to date. Zymergen was formed in 2013 and is based in Emeryville, California.


DEAL STATS #
Overall 1 of 3
Sector: Life Science M&A 1 of 3
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 3
Year: 2018 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-19 enEvolv

Medford, Massachusetts, United States

enEvolv, Inc. is a synthetic biology company that develops an enzyme and strain development platform to harness the power of evolution and create unique, commercial products by engineering the genomes of microbes. enEvolv was established in 2011 and is based in Medford, Massachusetts.

Buy -

Seller(S) 1

SELLER

Metagenics

Aliso Viejo, California, United States

Category Company
Founded 1983
Sector Medical Products
DESCRIPTION

Metagenics is a provider of medical foods and nutraceuticals to medical practitioners worldwide. Metagenics was founded in 1983 and is based in Aliso Viejo, California.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-05-31 Health World

Northgate, Australia

Health World Ltd. is a developer, manufacturer and supplier of nutritional supplements and natural medicines to healthcare professionals and consumers in Australia and New Zealand.

Buy -